Mildiomycin: a nucleoside antibiotic that inhibits protein synthesis.
Mildiomycin, a new nucleoside antibiotic, selectively inhibits protein synthesis in HeLa cells, and is less active in the inhibition of RNA or DNA synthesis. An increased inhibition of translation by mildiomycin is observed in cultured HeLa cells when they are permeabilized by encephalomyocarditis virus. This observation suggests that this antibiotic does not easily pass through the cell membrane, as occurs with other nucleoside and aminoglycoside antibiotics. The inhibition of translation is also observed in cell-free systems, such as endogenous protein synthesis in a rabbit reticulocyte lysate or the synthesis of polyphenylalanine directed by poly (U). Finally the mode of action of mildiomycin was investigated and the results suggest that the compound blocks the peptidyl-transferase center.
E
E
Feduchi
M
M
Cosín
L
L
Carrasco
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003596:Cytosine / Q000031:analogs & derivatives / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D006367:HeLa Cells / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D009705:Nucleosides / Q000494:pharmacology*; D010458:Peptidyl Transferases / Q000037:antagonists & inhibitors; D012313:RNA / Q000096:biosynthesis; D011817:Rabbits; D051381:Rats; D012156:Reticulocytes / Q000378:metabolism
D000900:Anti-Bacterial Agents; D009363:Neoplasm Proteins; D009705:Nucleosides; D012313:RNA; D003596:Cytosine; D004247:DNA; D010458:Peptidyl Transferases; C017539:mildiomycin